Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer

Por Kloft, C, Siegert, W, Jaehde, U
Publicado em 2003

Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans.

Por Jaehde, U, Sörgel, F, Stephan, U, Schunack, W
Publicado em 1994

Early postoperative substitution procedure of the antioxidant ascorbic acid (AA) in postoperative intensive care unit (ICU) patients

Por Ruemelin, A, Jaehde, U, Kerz, T, Krämer, M, Fauth, U
Publicado em 2004

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours

Por Fleischhack, G, Reif, S, Hasan, C, Jaehde, U, Hettmer, S, Bode, U
Publicado em 2001

Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)

Por Hagelstein, V., Ortland, I., Wilmer, A., Mitchell, S. A., Jaehde, U.
Publicado no Ann Oncol (2016)

Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.

Por Jaehde, U, Sörgel, F, Naber, K G, Zürcher, J, Schunack, W
Publicado em 1995

Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial

Por Lenssen, R., Schmitz, K., Griesel, C., Heidenreich, A., Schulz, J. B., Trautwein, C., Marx, N., Fitzner, C., Jaehde, U., Eisert, A.
Publicado no BMC Geriatr (2018)

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients

Por Pieck, A C, Drescher, A, Wiesmann, K G, Messerschmidt, J, Weber, G, Strumberg, D, Hilger, R A, Scheulen, M E, Jaehde, U
Publicado em 2008

Doripenem Treatment during Continuous Renal Replacement Therapy

Por Vossen, M. G., Wenisch, J. M., Maier-Salamon, A., Fritsch, A., Saria, K., Zuba, C., Jilch, S., Lemmerer, R., Unger, M., Jaehde, U., Jäger, W., Thalhammer, F.
Publicado no Antimicrob Agents Chemother (2016)

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer

Por Diekstra, MH, Fritsch, A, Kanefendt, F, Swen, JJ, Moes, DJAR, Sörgel, F, Kinzig, M, Stelzer, C, Schindele, D, Gauler, T, Hauser, S, Houtsma, D, Roessler, M, Moritz, B, Mross, K, Bergmann, L, Oosterwijk, E, Kiemeney, LA, Guchelaar, HJ, Jaehde, U
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)